Advertisement

Is Remdesivir a Disappointment?

Is Remdesivir a Disappointment?

Many people who are closely following developments in the COVID-19 pandemic are familiar with remdesivir. Gilead Sciences' (NASDAQ: GILD) investigational antiviral drug has been seen by many as a promising treatment option for the coronavirus. In February, Bruce Aylward of the World Health Organization said, "There is only one drug right now that we think may have real efficacy and that's remdesivir."